Tandem Diabetes Care’s Control-IQ+ Technology FDA Cleared for Pregnancy in Type 1 Diabetes
Tandem Diabetes Care’s Control-IQ+ automated insulin delivery technology has received FDA clearance for use during pregnancy in individuals with type 1 diabetes, enhancing management and care options for expecting mothers.
SAN DIEGO–(BUSINESS WIRE)—- $TNDM #diabetes–FDA clears Tandem Diabetes Care’s Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.